Molecular targets that link dioxin exposure to toxicity phenotypes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 127, Issue 1-2, 2011, Pages 96-101

  Yoshioka, Wataru ^a   Peterson, Richard E ^b   Tohyama, Chiharu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Aryl hydrocarbon receptor; Cyclooxygenase 2; Dioxin; Sox9; Toxicity

Indexed keywords

ARACHIDONIC ACID; BETA CATENIN; CYCLOOXYGENASE 2; DIOXIN; HYDROCARBON; WNT PROTEIN;

ARTICLE; BRAIN BLOOD FLOW; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; FETUS; GENE TARGETING; GENOTOXICITY; HUMAN; HYDRONEPHROSIS; JAW MALFORMATION; LIVER TOXICITY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PROSTATE; PUP (RODENT); TISSUE REGENERATION; ZEBRA FISH;

ANIMAL FINS; ANIMALS; BETA CATENIN; CYCLOOXYGENASE 2; DIOXINS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; JAW ABNORMALITIES; LIVER; MALE; MESENCEPHALON; MICE; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; WNT SIGNALING PATHWAY; ZEBRAFISH;

DANIO RERIO; MUS;

EID: 80053974926     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.12.005     Document Type: Article

References (56)

1. World Health Organization Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): executive summary Food Addit. Contam. 17 2000 223 240
2. M. Van den Berg, L.S. Birnbaum, M. Denison, M. De Vito, W. Farland, M. Feeley, H. Fiedler, H. Hakansson, A. Hanberg, L. Haws, M. Rose, S. Safe, D. Schrenk, C. Tohyama, A. Tritscher, J. Tuomisto, M. Tysklind, N. Walker, and R.E. Peterson The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds Toxicol. Sci. 93 2006 223 241 (Pubitemid 44400442)
3. P. Mocarelli, P.M. Gerthoux, E. Ferrari, D.G. Patterson Jr., S.M. Kieszak, P. Brambilla, N. Vincoli, S. Signorini, P. Tramacere, V. Carreri, E.J. Sampson, W.E. Turner, and L.L. Needham Paternal concentrations of dioxin and sex ratio of offspring Lancet 355 2000 1858 1863 (Pubitemid 30311877)
4. M. Kuratsune, H. Yoshimura, Y. Hori, M. Okumura, and Y. Masuda Yusho: A Human Disaster Caused by PCBs and Related Compounds 1996 Kyushu University Press Fukuoka
5. Y.L. Guo, M.L. Yu, and C.C. Hsu The Yucheng rice oil poisoning incident A. Shecter, T.A. Gasiewicz, Dioxins and Health 2003 John Wiley & Sons Hoboken, NJ, USA 893 919
6. International Agency for Research on Cancer Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans 1997 IARC Lyon, France
7. A. Schecter, and T.A. Gasiewicz Dioxin and Health 2003 John Wiley & Sons Hoboken
8. A. Poland, E. Glover, and A.S. Kende Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase J. Biol. Chem. 251 1976 4936 4946
9. J. Mimura, and Y. Fujii-Kuriyama Functional role of AhR in the expression of toxic effects by TCDD Biochim. Biophys. Acta 1619 2003 263 268 (Pubitemid 36160604)
10. F. Matsumura The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects Biochem. Pharmacol. 77 2009 608 626
11. F. Ohtake, A. Baba, Y. Fujii-Kuriyama, and S. Kato Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings Biochem. Biophys. Res. Commun. 370 2008 541 546
12. J.V. Schmidt, G.H. Su, J.K. Reddy, M.C. Simon, and C.A. Bradfield Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development Proc. Natl. Acad. Sci. U.S.A. 93 1996 6731 6736 (Pubitemid 26230378)
13. J. Mimura, K. Yamashita, K. Nakamura, M. Morita, T.N. Takagi, K. Nakao, M. Ema, K. Sogawa, M. Yasuda, M. Katsuki, and Y. Fujii-Kuriyama Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor Genes Cells 2 1997 645 654 (Pubitemid 127688610)
14. F.J. Gonzalez, and P. Fernandez-Salguero The aryl hydrocarbon receptor: studies using the AHR-null mice Drug Metab. Dispos. 26 1998 1194 1198
15. A.B. Okey, M.A. Franc, I.D. Moffat, N. Tijet, P.C. Boutros, M. Korkalainen, J. Tuomisto, and R. Pohjanvirta Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor Toxicol. Appl. Pharmacol. 207 2005 43 51
16. D.E. Chapman, and C.M. Schiller Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice Toxicol. Appl. Pharmacol. 78 1985 147 157 (Pubitemid 15111114)
17. A.B. Okey, L.M. Vella, and P.A. Harper Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene Mol. Pharmacol. 35 1989 823 830 (Pubitemid 19180673)
18. T. Moriguchi, H. Motohashi, T. Hosoya, O. Nakajima, S. Takahashi, S. Ohsako, Y. Aoki, N. Nishimura, C. Tohyama, Y. Fujii-Kuriyama, and M. Yamamoto Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse Proc. Natl. Acad. Sci. U.S.A. 100 2003 5652 5657 (Pubitemid 36576863)
19. C.M. Vezina, T.M. Lin, and R.E. Peterson AHR signaling in prostate growth, morphogenesis, and disease Biochem. Pharmacol. 77 2009 566 576
20. S.H. Allgeier, T.M. Lin, C.M. Vezina, R.W. Moore, W.A. Fritz, S.Y. Chiu, C. Zhang, and R.E. Peterson WNT5A selectively inhibits mouse ventral prostate development Dev. Biol. 324 2008 10 17
21. M.E. Hahn, S.I. Karchner, B.R. Evans, D.G. Franks, R.R. Merson, and J.M. Lapseritis Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics J. Exp. Zool. A Comp. Exp. Biol. 305 2006 693 706 (Pubitemid 44358297)
22. S.A. Carney, R.E. Peterson, and W. Heideman 2,3,7,8-Tetrachlorodibenzo-p- dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish Mol. Pharmacol. 66 2004 512 521 (Pubitemid 39329249)
23. H.C. Yin, H.P. Tseng, H.Y. Chung, C.Y. Ko, W.S. Tzou, D.R. Buhler, and C.H. Hu Influence of TCDD on zebrafish CYP1B1 transcription during development Toxicol. Sci. 103 2008 158 168 (Pubitemid 351524487)
24. S. Uno, T.P. Dalton, P.R. Sinclair, N. Gorman, B. Wang, A.G. Smith, M.L. Miller, H.G. Shertzer, and D.W. Nebert Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria Toxicol. Appl. Pharmacol. 196 2004 410 421 (Pubitemid 38496464)
25. P.G. Kopf, J.A. Scott, L.N. Agbor, J.R. Boberg, K.M. Elased, J.K. Huwe, and M.K. Walker Cytochrome P4501A1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin Toxicol. Sci. 2010
26. L.K. Mathew, M.T. Simonich, and R.L. Tanguay AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration Biochem. Pharmacol. 77 2009 498 507
27. E.A. Andreasen, L.K. Mathew, and R.L. Tanguay Regenerative growth is impacted by TCDD: gene expression analysis reveals extracellular matrix modulation Toxicol. Sci. 92 2006 254 269 (Pubitemid 43985808)
28. L.K. Mathew, S.S. Sengupta, J. Ladu, E.A. Andreasen, and R.L. Tanguay Crosstalk between AHR and Wnt signaling through R-Spondin1 impairs tissue regeneration in zebrafish FASEB J. 22 2008 3087 3096
29. K.M. Xiong, R.E. Peterson, and W. Heideman Aryl hydrocarbon receptor-mediated down-regulation of sox9b causes jaw malformation in zebrafish embryos Mol. Pharmacol. 74 2008 1544 1553
30. H.M. Theobald, G.L. Kimmel, and R.E. Peterson Developmental and reproductive toxicity of dioxins and related chemicals A. Schecter, T.A. Gasiewicz, Dioxin and Health 2003 John Wiley & Sons Hoboken, NJ, USA 329 432
31. R.L. Chevalier, B.A. Thornhill, M.S. Forbes, and S.C. Kiley Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy Pediatr. Nephrol. 25 2010 687 697
32. J.M. Belarmino, and B.A. Kogan Management of neonatal hydronephrosis Early Hum. Dev. 82 2006 9 14 (Pubitemid 43163034)
33. J.L. Zeidel, and G. Pirtskhalaishvili Urinary tract obstruction B.M. Brenner, Brenner and Rector's The Kidney 2004 Saunders Philadelphia 1867 1894
34. N. Takahashi, D.R. Chernavvsky, R.A. Gomez, P. Igarashi, H.J. Gitelman, and O. Smithies Uncompensated polyuria in a mouse model of Bartter's syndrome Proc. Natl. Acad. Sci. U.S.A. 97 2000 5434 5439 (Pubitemid 30313736)
35. J.N. Lorenz, N.R. Baird, L.M. Judd, W.T. Noonan, A. Andringa, T. Doetschman, P.A. Manning, L.H. Liu, M.L. Miller, and G.E. Shull Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome J. Biol. Chem. 277 2002 37871 37880
36. + channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice J. Biol. Chem. 277 2002 37881 37887 (Pubitemid 35153514)
37. D.M. Kaji, H.S. Chase Jr., J.P. Eng, and J. Diaz Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells Am. J. Physiol. 271 1996 C354 361
38. R.M. Nusing, A. Treude, C. Weissenberger, B. Jensen, M. Bek, C. Wagner, S. Narumiya, and H.W. Seyberth Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome J. Am. Soc. Nephrol. 16 2005 2354 2362 (Pubitemid 41725053)
39. A. Puga, A. Hoffer, S. Zhou, J.M. Bohm, G.D. Leikauf, and H.G. Shertzer Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin Biochem. Pharmacol. 54 1997 1287 1296 (Pubitemid 27521039)
40. T. Yang Regulation of cyclooxygenase-2 in renal medulla Acta Physiol. Scand. 177 2003 417 421 (Pubitemid 36411578)
41. F. Matsumura On the significance of the role of cellular stress response reactions in the toxic actions of dioxin Biochem. Pharmacol. 66 2003 527 540 (Pubitemid 37281272)
42. N. Nishimura, F. Matsumura, C.F. Vogel, H. Nishimura, J. Yonemoto, W. Yoshioka, and C. Tohyama Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxin Toxicol. Appl. Pharmacol. 231 2008 374 383
43. M. Nie, L. Pang, H. Inoue, and A.J. Knox Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements transcription factors, and histone h4 acetylation Mol. Cell Biol. 23 2003 9233 9244 (Pubitemid 37499810)
44. B. Dong, N. Nishimura, C.F. Vogel, C. Tohyama, and F. Matsumura TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys Biochem. Pharmacol. 79 2010 487 497
45. W. Yoshioka, T. Akagi, N. Nishimura, H. Shimizu, C. Watanabe, and C. Tohyama Severe toxicity and cyclooxygenase (COX)-2 mRNA increase by lithium in the neonatal mouse kidney J. Toxicol. Sci. 34 2009 519 525
46. H. Teraoka, A. Kubota, W. Dong, Y. Kawai, K. Yamazaki, C. Mori, Y. Harada, R.E. Peterson, and T. Hiraga Role of the cyclooxygenase 2-thromboxane pathway in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced decrease in mesencephalic vein blood flow in the zebrafish embryo Toxicol. Appl. Pharmacol. 234 2009 33 40
47. S. Park, B. Dong, and F. Matsumura Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells Biochemistry 46 2007 899 908 (Pubitemid 46133606)
48. S.A. Carney, A.L. Prasch, W. Heideman, and R.E. Peterson Understanding dioxin developmental toxicity using the zebrafish model Birth Defects Res. A Clin. Mol. Teratol. 76 2006 7 18 (Pubitemid 43227673)
49. W. Dong, F. Matsumura, and S.W. Kullman TCDD induced pericardial edema and relative COX-2 expression in medaka (Oryzias latipes) embryos Toxicol. Sci. 2010
50. M.K. Bunger, E. Glover, S.M. Moran, J.A. Walisser, G.P. Lahvis, E.L. Hsu, and C.A. Bradfield Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor Toxicol. Sci. 106 2008 83 92
51. M. Nukaya, B.C. Lin, E. Glover, S.M. Moran, G.D. Kennedy, and C.A. Bradfield The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes J. Biol. Chem. 285 2010 35599 35605
52. K. Pande, S.M. Moran, and C.A. Bradfield Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines Mol. Pharmacol. 67 2005 1393 1398 (Pubitemid 40594137)
53. F. Ohtake, A. Baba, I. Takada, M. Okada, K. Iwasaki, H. Miki, S. Takahashi, A. Kouzmenko, K. Nohara, T. Chiba, Y. Fujii-Kuriyama, and S. Kato Dioxin receptor is a ligand-dependent E3 ubiquitin ligase Nature 446 2007 562 566 (Pubitemid 46514731)
54. R. Duan, W. Porter, I. Samudio, C. Vyhlidal, M. Kladde, and S. Safe Transcriptional activation of c-fos protooncogene by 17 beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition Mol. Endocrinol. 13 1999 1511 1521 (Pubitemid 30650592)
55. F. Ohtake, Y. Fujii-Kuriyama, and S. Kato AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions Biochem. Pharmacol. 77 2009 474 484
56. W. Yoshioka, W. Higashiyama, and C. Tohyama Reduction in Mir-101a Expression Level and Associated Changes in TCDD-Exposed Mouse Liver, 49th Annual Meeting and ToxExpo 2010 Oxford University Press Salt Lake City Utah, USA 365